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Chronic cluster headache (CCH) is a rare and extremely
disabling headache syndrome with a recent clinical sys-
tematization of its clinical frame from the European
Headache Federation [1]. We present a case of a young
man affected by drug-resistant chronic CH (rCCH) who
showed improvement after a two-time combined
supraorbital and occipital nerve stimulation (S-ONS).
The clinical improvement was still present at 6-month
follow-up.
A 37-year-old man (LB), with an 18-year history of epi-
sodic CH ab initio, was referred to our Regional Referral
Headache Centre first, and then to the Pain Unit, because
the headache had become chronic (CCH), and the patient
suffered from daily cluster attacks (4-6/day). The patient
became progressively unresponsive to prophylactic/acute
therapies, including O2-therapy, verapamil up to 600 mg/
day, external vagus nerve stimulation, etc.
The headache was strictly left-sided. The pain
emerged at the left occipital region and migrated
towards the ipsilateral eye, becoming throbbing and
increasing up to 10/10. It remained fixed within the
orbital area between 45 and 80 minutes, accompanied
by concurrent, ipsilateral conjunctival injection and
tearing. Brain magnetic resonance imaging excluded any
underlying lesions.
Sumatriptan 6 mg i.m. maintained over time its efficacy,
but during the last year the risk of serious cardiac side
effects suggested to look for an alternative treatment to
reduce its harmful overuse.
After careful psychological assessment, the patient was
considered eligible for occipital nerve stimulation (ONS)
trial. Three weeks later he was implanted with a
>50%/<85% reduction of attack number and intensity of
pain. Unfortunately, three months after surgery, the
patient complained of a reappearance of his usual severe
CH attack (VAS 10), periorbitally located. We decided
to implant an additional electrocatheter stimulating
bilaterally the supraorbital nerves (SON). At six-month
follow-up the patient referred suffering of 1 attack a
week, of mild/moderate intensity, not altering his overall
improved quality of life.
ONS was efficient in most of the rCCH patients
reported in the literature with low complication rates [2].
In our patient, the ONS was partially effective in relieving
symptoms, achieving excellent pain relief only when
supraorbital stimulation (SON) was associated [Fig. 1].
Evidence from future RCTs should support this approach
in order to give guidelines for a multimodal approach to
similar rare/unusual case reports.
Written informed consent to publication was obtained
from the patient(s).
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Figure 1 Radiographic image revealing multiple - ONS plus SNO - implant in rCCH patient.
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